Discovery of Novel & Potent Inhibitors Targeting the NLRP3 Pathway

Time: 11:00 am
day: Conf Day 2


  • Using the physic-based computational platform, allied with machine learning techniques to enable the identification of NLRP3 inhibitors
  • Highlighting the inhibitor’s capability to target both peripheral and CNS diseases
  • Harnessing a range of functional and mechanistic cellular assays, in vivo pharmacodynamic and disease models to explore pathway inhibition